Envejecimiento (prevención)

5-HTP is the immediate precursor to serotonin and passes the blood-brain barrier more readily than tryptophan. Serotonin deficiency is mechanistically linked to brain fog, depression, and impaired cognition. Clinical studies show 5-HTP supplementation increases central serotonin synthesis and improves mood, cognitive symptoms, and mental clarity in depression, fibromyalgia, and related conditions that prominently feature brain fog.

Acetyl-L-Carnitine (ALCAR) crosses the blood-brain barrier and donates acetyl groups for acetylcholine synthesis, supporting neuronal energy metabolism. Clinical trials show 2 g/day significantly improved mental fatigue and cognitive concentration in chronic fatigue syndrome patients (p=0.015). Meta-analyses of RCTs suggest it may slow cognitive decline in mild cognitive impairment and early Alzheimer's disease, and it has been studied for hepatic encephalopathy-related cognitive dysfunction.

Acetyl-L-Tyrosine is a more bioavailable form of L-tyrosine, a precursor to catecholamines including dopamine and norepinephrine. Tyrosine supplementation has been shown in RCTs to counteract cognitive decline under conditions of stress, sleep deprivation, and cold exposure that mimic brain fog states. It is used to support working memory and executive function when neurotransmitter depletion contributes to cognitive fatigue.

ALA reduces oxidative stress and neuroinflammatory markers relevant to the pathophysiology of cognitive clouding. A clinical RCT in surgical patients showed ALA significantly reduced sevoflurane-induced oxidative stress and improved postoperative cognitive function. Evidence specifically targeting 'brain fog' as a distinct entity is limited but grounded in ALA's established antioxidant activity in the brain.

In the 2006 (n=41) and 2012 (n=257) open-label CFS/FMS studies, D-ribose at 15 g/day produced statistically significant improvements in self-reported mental clarity alongside energy and pain outcomes. The brain's high ATP demand provides mechanistic plausibility. No RCTs targeting brain fog specifically have been conducted.

Ashwagandha (Withania somnifera) is a well-studied Ayurvedic adaptogen whose withanolides modulate the HPA axis, lowering cortisol, reducing neuroinflammation, and supporting acetylcholine pathways. Multiple RCTs show it improves memory, attention, executive function, and reduces mental fatigue. A 2024 RCT of 59 healthy adults (225 mg/day) found significant improvements in word recall, vigilance, and reduced tension/fatigue.

Bacopa monnieri is one of the most rigorously tested herbs for memory and cognitive clarity. Its active bacosides enhance acetylcholine, GABA, and serotonin activity, and exert antioxidant neuroprotection. Multiple RCTs and systematic reviews confirm that 300–450 mg/day of standardized extract over 8–12 weeks significantly improves memory acquisition, retention, and reduces forgetting rate in healthy adults and those with cognitive impairment.

Bacopin is a standardized proprietary extract of Bacopa monnieri, containing defined concentrations of bacosides. The same clinical evidence base supporting Bacopa monnieri applies to Bacopin, as it is used in clinical trials as the standardized form. It supports memory, reduces forgetting rate, and improves cognitive processing relevant to brain fog.

Bacosides are the primary active saponin glycosides of Bacopa monnieri responsible for its nootropic effects. Clinical and preclinical research demonstrates they enhance synaptic plasticity, acetylcholine synthesis, and antioxidant neuroprotection—mechanisms directly addressing the neurochemical substrates of brain fog.

Clinical evidence shows blueberry supplementation improves psychomotor speed, delayed recall, and processing speed in older adults and MCI populations—domains commonly impaired in brain fog. Cerebral blood flow improvements measured via fMRI provide objective mechanistic support.

B12 deficiency is a well-established reversible cause of brain fog, cognitive slowing, and confusion. Iron deficiency impairs cognitive processing via reduced cerebral oxygen delivery. Bovine liver's dense B12 and heme iron content address two primary nutritional drivers of brain fog. Choline supports acetylcholine synthesis needed for clear cognitive function.

Caffeine acutely reduces symptoms consistent with brain fog—including impaired alertness, slow cognition, and poor concentration—by blocking adenosine receptors and increasing dopaminergic and noradrenergic signaling. A large UK Biobank study (up to 434,900 participants) found that recent caffeine drinking was associated with better performance on multiple cognitive tasks. However, excessive intake or withdrawal can paradoxically worsen cognitive clarity.

DHA maintains neuronal membrane fluidity and supports neurotransmitter function relevant to mental clarity. Clinical trials show DHA-dominant supplementation supports cognitive processing including reaction time, cerebral blood flow, and perceptual speed. The evidence is primarily extrapolated from cognitive function RCTs in aging and clinical populations.

Caprylic acid's rapid conversion to ketones provides an alternative cerebral energy source that may transiently relieve cognitive sluggishness (brain fog) associated with cerebral glucose hypometabolism. Human data supporting this are mostly indirect, derived from MCT/ketone trials in aging and mild cognitive impairment cohorts. Acute benefits within 90 minutes of a C8 dose are reported.

Choline is an essential nutrient and direct precursor to acetylcholine, the neurotransmitter most critical for memory and attention. Dietary choline insufficiency is associated with cognitive impairment and symptoms consistent with brain fog. Observational studies link higher choline intake to better cognitive performance, verbal memory, and processing speed in adults.

Citicoline (CDP-choline) is a well-studied nootropic and a key precursor for phosphatidylcholine synthesis in brain cell membranes. A 12-week randomized, double-blind, placebo-controlled trial in 100 older adults with age-associated memory impairment showed 500 mg/day citicoline significantly improved episodic memory and composite memory scores versus placebo. It is used clinically for cognitive dysfunction and brain fog related to inadequate choline availability.

Coffee cherry extract has been shown to reduce reaction time and improve accuracy in cognitively demanding tasks in older adults with mild cognitive decline. Coffeeberry extract also attenuates self-reported mental fatigue during fatiguing cognitive tasks. BDNF upregulation and reduced neuroinflammation are the proposed mechanisms for clearing cognitive fog.

CoQ10 is an essential mitochondrial cofactor that supports ATP production in brain cells, which consume approximately 20% of the body's energy. It also acts as a neuroprotective antioxidant. A meta-analysis found moderate evidence that CoQ10 supplementation (100–400 mg/day) improves general cognitive performance in older adults, and low CoQ10 is associated with cognitive decline and reduced antioxidant defenses.

Creatine supports the recycling of ATP in both muscle and brain tissue. A study in Scientific Reports found a single high-dose of creatine significantly improved cognitive performance and brain energy metabolism in sleep-deprived subjects. Multiple RCTs show creatine supplementation improves working memory and intelligence, especially under cognitively demanding or sleep-deprived conditions associated with brain fog.

Creatine monohydrate raises measurable brain creatine concentrations and supports neural ATP availability, which may alleviate cognitive fatigue and brain fog, particularly in states of energetic depletion. A small trial in ME/CFS patients showed high-dose creatine improved reaction times and memory recall alongside increased creatine in prefrontal brain regions.

Human open-label trials in CFS/fibromyalgia patients reported significant improvement in 'mental clarity' alongside energy and pain outcomes after D-ribose supplementation. The proposed mechanism is restoration of ATP availability in metabolically stressed neural tissue. Evidence is limited to uncontrolled studies without a placebo arm, so findings should be interpreted cautiously.

DHA is a long-chain omega-3 fatty acid constituting approximately 97% of the omega-3 fatty acids in the brain and a major component of neuronal cell membranes. A 6-month double-blind RCT in 176 adults with low omega-3 intake found 1.16 g/day DHA significantly improved episodic and working memory versus placebo. Low DHA is associated with cognitive impairment, neuroinflammation, and brain fog.

EGCG has demonstrated improvements in cognitive performance and cerebral blood flow parameters in human double-blind crossover studies. It inhibits amyloid-beta aggregation, reduces tau phosphorylation, and activates BDNF pathways relevant to cognitive clarity. Clinical evidence from Down syndrome trials also shows improved adaptive cognitive function.

Eleuthero has documented effects on cognitive performance, mental fatigue, and alertness in Soviet-era research encompassing large populations, and in modern placebo-controlled studies. The EMA recognizes it for asthenia symptoms including mental fatigue. Its active compounds cross the blood-brain barrier in animal models, supporting a plausible mechanism.

GABA is the brain's primary inhibitory neurotransmitter, and dysregulation of GABAergic signaling is implicated in anxiety, hyperarousal, and stress-related brain fog. Supplemental GABA has been studied for reducing stress-induced cognitive impairment. Some RCTs show GABA supplementation (100–200 mg) reduces stress and anxiety parameters that contribute to mental fog, and promotes relaxed alertness via alpha brain wave enhancement.

Ginkgo biloba is one of the most extensively studied herbs for cognitive function, with a long history of use in Traditional Chinese Medicine for mental clarity. Standardized extracts (24% flavone glycosides, 6% terpene lactones) enhance cerebral blood flow, inhibit platelet-activating factor, and act as antioxidants. Multiple RCTs and meta-analyses support improvements in attention, memory, and processing speed in adults with cognitive impairment and age-related cognitive decline.

Ginkgosides (ginkgolide terpene lactones from Ginkgo biloba) are among the primary bioactive constituents responsible for ginkgo's cognitive effects. They antagonize platelet-activating factor, improve cerebral microcirculation, and exhibit neuroprotective properties. Their clinical evidence overlaps with and is the mechanistic basis for the Ginkgo biloba clinical trial evidence for cognitive support.

Ginseng (Panax ginseng) is a widely studied adaptogenic herb with a millennia-long history in Traditional Chinese and Korean medicine for mental fatigue and cognitive clarity. Its active ginsenosides modulate HPA axis stress responses, neurotransmitter systems, and cerebral blood flow. Multiple RCTs demonstrate improvements in working memory, attention, and mental processing speed, particularly under conditions of fatigue.

Ginsenosides are the primary bioactive saponins of Panax ginseng responsible for its nootropic effects. They modulate HPA axis stress responses, enhance cerebral blood flow, and support cholinergic and monoaminergic neurotransmission. Clinical trials using ginsenoside-standardized ginseng extracts show improvements in working memory, attention, and cognitive performance relevant to brain fog.

Gotu Kola's anti-inflammatory, antioxidant, and cholinergic-enhancing properties address key mechanistic drivers of brain fog. Clinical studies in elderly populations and post-stroke patients document improved cognitive clarity and mental function. Reductions in neuroinflammatory markers such as TNF-α correlate with cognitive improvement in RCTs.

Glycerophosphocholine (GPC, alpha-GPC) is a highly bioavailable choline donor that crosses the blood-brain barrier and directly increases acetylcholine synthesis. Multiple RCTs demonstrate alpha-GPC (600–1200 mg/day) improves cognitive function, memory, attention, and orientation in patients with mild-to-moderate Alzheimer's disease and vascular dementia, with benefits observed within 3–6 months of treatment.

Clinical trials show guarana, particularly in combination with vitamins and minerals, can reduce mental fatigue and improve sustained attention. A double-blind RCT in 129 healthy young adults found a vitamin/mineral/guarana combination improved speed and accuracy on a rapid visual information processing task and attenuated the build-up of mental fatigue. A 2023 meta-analysis found a significant effect on response speed across cognitive tasks.

Hericenones are aromatic compounds isolated from Lion's Mane mushroom (Hericium erinaceus) fruiting bodies shown to stimulate nerve growth factor (NGF) synthesis in neuronal cells. They cross the blood-brain barrier and, along with erinacines, form the mechanistic basis for Lion's Mane's cognitive and neuroprotective effects studied in clinical trials for brain fog and cognitive impairment.

Hericium erinaceus (Lion's Mane mushroom) is the most clinically studied mushroom for brain fog and cognitive support. A 16-week double-blind RCT in 30 adults (50–80 years) with mild cognitive impairment found 3 g/day significantly improved cognitive function scores versus placebo. Its bioactive hericenones and erinacines stimulate NGF production, supporting neural regeneration and neuroprotection.

Huperzine A is a naturally occurring alkaloid from Huperzia serrata that potently inhibits acetylcholinesterase, increasing acetylcholine levels in the brain and directly addressing cholinergic deficits associated with brain fog and cognitive impairment. A systematic review and meta-analysis of RCTs found it improves cognitive function, daily living activity, and global clinical assessment in Alzheimer's patients, though methodological quality of studies was variable.

Iodine deficiency impairs thyroid hormone synthesis, which slows metabolism and brain signalling, producing symptoms including mental sluggishness and 'brain fog'. Studies in communities with severe iodine deficiency document apathy and sluggishness in adults. Correcting deficiency restores thyroid hormone levels and can reverse these cognitive symptoms. Evidence is strongest for deficiency states; supplementation in already-sufficient individuals is not well-evidenced.

L-Theanine is an amino acid from green tea that crosses the blood-brain barrier and promotes alpha brain waves, producing relaxed alertness without sedation. A 2025 systematic review and meta-analysis of RCTs confirmed its beneficial effects on cognitive performance. When combined with caffeine, it significantly improves attention, working memory, and reaction time—directly targeting the focus and clarity deficits of brain fog.

L-tyrosine is the amino acid precursor to dopamine, norepinephrine, and epinephrine—catecholamines that are depleted under stress, sleep deprivation, and cognitive fatigue. Multiple RCTs demonstrate L-tyrosine supplementation counteracts stress-induced cognitive decline, improving working memory, cognitive flexibility, and alertness under demanding conditions that mirror brain fog states.

Lemon balm's calming, mood-improving, and stress-reducing effects in clinical trials are closely related to reduction of subjective mental fog. Stress and anxiety are primary drivers of brain fog, and lemon balm's GABAergic and cholinergic actions reduce cognitive interference from these states. The Kennedy et al. (2002, 2003) crossover studies showed improved task accuracy and calmness.

Lion's Mane mushroom (Hericium erinaceus) is clinically studied for brain fog and cognitive impairment. Its unique bioactives, hericenones and erinacines, stimulate nerve growth factor synthesis. A 16-week double-blind RCT in adults aged 50–80 with mild cognitive impairment found 3 g/day significantly improved cognitive scores versus placebo. Additional trials in healthy adults show improved speed of cognitive performance.

Luteolin has been directly investigated for brain fog, with a 2015 Frontiers in Neuroscience review proposing it as a targeted intervention. A liposomal luteolin formulation improved attention in children with autism spectrum disorders and reduced brain fog in mastocytosis patients. A clinical study of PEA+luteolin in COVID-19 patients also showed improvements in cognitive symptoms.

Magnesium is essential for over 300 enzymatic reactions and plays a critical role in synaptic plasticity, NMDA receptor function, and neurotransmitter synthesis. A study of 2,466 adults aged 60+ found higher magnesium levels associated with significantly better attention and memory. Low magnesium is linked to reduced cognitive function, neuroinflammation, and impaired stress responses—all contributors to brain fog.

MCTs are rapidly converted to ketone bodies in the liver, providing an alternative cerebral fuel when glucose metabolism is impaired. Clinical data primarily from MCI and Alzheimer's patients support that MCT-induced ketosis can reduce cognitive symptom burden associated with brain energy deficits. Evidence in otherwise healthy adults with brain fog is extrapolated from these populations rather than directly tested.

Methylcobalamin is the neurologically active coenzyme form of vitamin B12. B12 deficiency causes demyelination, elevated homocysteine, and cognitive impairment presenting as brain fog. A study in 202 patients with cognitive impairment and low/deficient B12 found supplementation improved cognition in 84% and memory/attention scores in 78%. Methylcobalamin is the preferred form for neurological applications.

N-Acetyl Cysteine is a precursor to glutathione, the brain's primary antioxidant, and modulates glutamate neurotransmission. It has been studied for brain fog in post-COVID syndrome and neuropsychiatric conditions. A 2021 PMC review found NAC effective for treating neuropsychiatric symptoms including cognitive dysfunction in post-COVID/PCS, and preclinical and clinical data support its anti-neuroinflammatory and neuroprotective effects.

NMN is a direct precursor to NAD+, a coenzyme critical for mitochondrial energy production in brain cells. NAD+ levels decline with age, impairing cerebral bioenergetics and contributing to cognitive fatigue and brain fog. Preclinical studies show NMN prevents diabetes-induced cognitive impairment and restores hippocampal NAD+. A human RCT found NMN supplementation improved muscle metabolism; evidence for direct brain fog relief in humans is preliminary.

Omega-3 fatty acids, particularly EPA and DHA, are critical components of neuronal membranes and precursors to anti-inflammatory resolvins and protectins. Multiple RCTs and reviews support their role in reducing neuroinflammation and improving cognitive symptoms including attention, memory, and processing speed relevant to brain fog. A study in 176 adults found 1.16 g/day DHA for 6 months significantly improved episodic and working memory.

PC has been studied in clinical settings involving post-viral brain fog. As a choline donor and structural membrane lipid, it supports neuronal membrane integrity and ACh synthesis. A multicenter trial investigated PC in post-COVID cognitive impairment with brain fog.

Phosphatidylserine (PS) is a phospholipid concentrated in neuronal cell membranes critical for signal transduction, neurotransmitter release, and neuronal apoptosis regulation. The FDA has allowed a qualified health claim for PS and cognitive dysfunction. Multiple RCTs demonstrate PS supplementation (100–400 mg/day) improves memory, attention, and processing speed in adults with age-related cognitive decline—key brain fog symptoms.

Pregnenolone's dual action on NMDA (enhancing cognitive alertness) and GABA-A (providing inhibitory calm) receptors is proposed to stabilize mood and clear brain fog without overstimulation. Neurosteroid deficits have been linked to cognitive impairment in aging and psychiatric illness, and pregnenolone supplementation has improved cognitive scores in clinical populations.

Progesterone and its metabolite ALLO influence cognitive function through GABA-A modulation and neuroprotective effects on brain regions involved in memory and executive function. A 2018 Stanford study found progesterone levels positively and significantly predicted verbal memory and global cognition in recently postmenopausal women. Evidence suggests micronized progesterone may support cognitive outcomes better than synthetic progestins.

Rhodiola rosea is an adaptogenic herb studied extensively for mental and physical fatigue, closely aligned with brain fog symptoms. A double-blind crossover RCT found standardized Rhodiola extract (SHR-5) significantly improved total mental performance, short-term memory, and cognitive concentration in physicians during night duty. Multiple systematic reviews confirm its anti-fatigue and cognitive-enhancing effects under stress.

Rosemary has been studied for cognitive clarity and mental fatigue in human trials. A study in COPD patients found rosemary hydroalcoholic extract improved cognitive function and reduced fatigue-associated cognitive impairment. Traditional medicine classifies rosemary as a tonic herb for physical and mental fatigue.

Saffron (Crocus sativus) and its bioactives crocin and safranal act as serotonin reuptake inhibitors and antioxidants in the brain. Multiple RCTs show saffron (30 mg/day) significantly improves depression and cognitive symptoms including attention, memory, and mental clarity. A 2022 meta-analysis of RCTs confirmed saffron's efficacy for improving cognitive function and depression—conditions closely associated with brain fog.

SAMe is the body's primary methyl donor, essential for synthesizing neurotransmitters including serotonin, dopamine, norepinephrine, and phosphatidylcholine. SAMe deficiency is associated with cognitive dysfunction and depression, both characterized by brain fog. Multiple European clinical trials demonstrate SAMe improves depression (which includes cognitive fog symptoms), and it is approved as a prescription drug for depression in several countries.

Sulforaphane crosses the blood-brain barrier and upregulates brain glutathione and antioxidant enzymes, reducing neuroinflammation implicated in cognitive sluggishness. A human RCT in healthy older adults showed SFN supplementation improved processing speed. Preclinical data support reductions in LPS-induced cognitive impairment.

The 2-year RCT demonstrating tocotrienol attenuation of white matter lesion progression is directly relevant to brain fog, as WML accumulation is associated with mental clarity deficits, confusion, and reduced cognitive processing. Tocotrienols' neuroprotective effects on white matter integrity support their relevance to brain fog.

Clinical trials show curcumin supplementation significantly improves working memory and cognitive speed, particularly in older adults and those with metabolic impairment. A systematic review of clinical trials found curcumin associated with statistically significant improvements in cognitive performance and serum biomarkers across multiple populations. Effects on attention and processing speed are also reported.

Thiamine is critical for brain energy production, and even mild deficiency impairs the mitochondrial ATP generation that the brain requires for cognitive clarity. Clinically, thiamine deficiency is a recognized and reversible cause of cognitive impairment, confusion, and mental dullness. Prompt thiamine repletion in deficient individuals consistently resolves these symptoms.

Vitamin B12 deficiency is one of the most well-documented nutritional causes of brain fog. A study in 202 patients with cognitive impairment and low/deficient B12 found supplementation improved cognition in 84% and memory/attention scores in 78%. A cross-sectional study of ~39,000 people found low B12 significantly associated with poorer attention and memory. B12 supports myelin synthesis, homocysteine clearance, and neurotransmitter production.

Vitamin B6 (pyridoxine) is essential for synthesizing serotonin, dopamine, norepinephrine, GABA, and for homocysteine clearance. Deficiency is associated with cognitive impairment, depression, and brain fog. Population studies link low B6 to poorer memory and attention, and the VITACOG trial found high-dose B6 (with B12 and folate) slowed brain atrophy in MCI patients.

Folate is essential for one-carbon metabolism, homocysteine clearance, and synthesis of SAMe—all critical for brain neurotransmitter production and myelin integrity. Deficiency causes elevated homocysteine, neuroinflammation, and cognitive impairment including brain fog. The VITACOG trial found high-dose folate (with B12 and B6) slowed brain atrophy by ~30% in MCI patients with elevated homocysteine. Low folate is directly associated with memory and concentration difficulties.

5-Methyltetrahydrofolate (5-MTHF) is the bioactive, blood-brain-barrier-permeable form of folate, directly usable without hepatic conversion. It is especially important for individuals with MTHFR polymorphisms who cannot efficiently convert dietary folic acid. Supplementation with 5-MTHF corrects hyperhomocysteinemia, supports neurotransmitter synthesis, and addresses brain fog driven by folate deficiency or impaired folate metabolism.

Vitamin D deficiency is strongly associated with cognitive impairment and brain fog. Vitamin D receptors are distributed throughout the brain, and vitamin D modulates neurotrophin synthesis, neuroinflammation, and neurotransmitter function. Multiple studies show low vitamin D correlates with depressive symptoms and cognitive deficits, while supplementation can improve both—including the concentration and memory difficulties characteristic of brain fog.

Zinc is an essential trace mineral and cofactor for over 300 enzymes, including those involved in neurotransmitter synthesis, antioxidant defense, and DNA repair. Zinc deficiency is associated with cognitive impairment, depression, and brain fog. Clinical studies show zinc supplementation can improve cognitive function, attention, and memory, particularly in those with insufficient zinc status.

Difficulty concentrating and cognitive cloudiness are documented traditional indications for adrenal cortex extract, framed within the 'hypoadrenal syndrome' construct used by early 20th-century practitioners. No clinical trial data support adrenal cortex supplements for brain fog specifically. These cognitive symptoms overlap substantially with other diagnosable conditions.

In TCM, Yuan Zhi specifically addresses the concept of 'phlegm misting the mind'—a clinical state encompassing mental fogginess, difficulty concentrating, and cognitive sluggishness. This aligns conceptually with modern 'brain fog.' Preclinical mechanistic support exists via cholinergic enhancement and BDNF upregulation, but no brain fog-specific human trials exist.

Polygala root is traditionally used in TCM for 'forgetfulness,' 'disorientation,' and mental cloudiness—conditions resembling what is now called brain fog. Its mechanisms of action (cholinergic enhancement, BDNF upregulation, anti-inflammatory, antioxidant) are all relevant to cognitive clarity, though no clinical trial uses brain fog as a defined endpoint.